Skip to main content

New Clues to Treating a Disease That Prevents Children From Swallowing, Eating

Medically reviewed by Drugs.com.

By Cara Murez HealthDay Reporter

TUESDAY, Aug. 1, 2023 -- Children who have a chronic immune system disease that can prevent them from eating may eventually have a new treatment, decades after the condition was first identified.

“Parents and doctors may not be aware of this, but this is a very prominent and serious disease in the pediatric population, and it is increasing in number because it is directly related to food allergens, which are also on the rise,” said lead study author Dr. Anil Mishra, director of the Eosinophilic Disorder Center at the Tulane University School of Medicine in New Orleans.

“In this study, we show that after treating the disease in animals, the disease is gone and completely in remission," he said in a university news release.

Eosinophilic esophagitis (EoE) can be triggered by food or airborne allergies.

This causes eosinophils, which are white blood cells, to build up in the lining of the esophagus. This reaction causes the esophagus to shorten and the esophageal wall to thicken, which can make it difficult to swallow and cause food to get stuck in the throat.

The study, conducted in mice, found that the disease is caused by interleukin-18 (IL-18), a protein involved in the innate immune response. It can cause inflammation if produced in excess.

An allergen entering the body activates a pathway that leads to the release of pro-inflammatory proteins like IL-18 and the eosinophil production that damages the esophagus, but researchers found that inhibiting this NLRP3 pathway and the release of IL-18 prevented the development of EoE from both food and airborne allergens. However, animal research doesn't always produce the same results in humans.

EoE was identified in the 1990s and affects about 1 in 2,000 adults and 1 in 1,500 children. In kids, this can pose greater risks because difficulty feeding can lead to malnutrition, weight loss and poor growth.

For many years, EoE was misdiagnosed as gastrointestinal reflux disease (GERD). However, GERD medication was ineffective for treating the condition.

This new finding replaces decades of thinking that Th2 (T helper 2) cells play a major role in triggering EoE, according to researchers.

“Given the paucity of mechanistic information and treatment strategies for EoE, we feel the proposed studies are highly relevant and are poised to have a major impact on establishing the significance of NLRP3-IL-18 pathway in the initiation of EoE pathogenesis,” Mishra said.

The findings were published July 31 in the journal Nature’s Communications Biology.

Sources

  • Tulane University, news release, July 31, 2023

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Posted August 2023

Read this next

Early Exposure to Peanuts Can Prevent Long-Term Allergy

WEDNESDAY, May 29, 2024 -- Feeding kids peanuts early in childhood can drastically reduce their risk of developing a peanut allergy, a new clinical trial reports. Children...

Your Allergy Meds Come With Hazards: Be Aware

SATURDAY, May 18, 2024 -- People with seasonal allergies often turn to over-the-counter and prescription medicines to relieve symptoms like coughing, sneezing, runny nose...

Test Might Predict Which Kids Will Outgrow Peanut Allergy

MONDAY, May 13, 2024 -- About a third of young children who are allergic to peanuts will outgrow the allergy by the age of 10, and an antibody test might predict who those kids...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.